While as of yet, KCNK3 and ABCC8 mutations are the only channelopathies known to cause PAH, there is growing data supporting the significant role that potassium channels play in the cellular mechanisms underlying abnormal PAEC and PASMC behavior [1]. Here, KCNA3 is linked to pulmonary arterial hypertension.